Early access
Be first to know when rapid Phe testing comes home.
Join the early access list for updates on the PQS1.0 monitor and the Omaroon care platform, and invitations to take part as we test and grow.
What you'll get
Updates that matter
Milestones on the PQS1.0 monitor and the care platform. A few emails a year, not a newsletter flood.
First look at pilots
Invitations to user research, pilots and early evaluation as they open up for families and clinics.
Built with the PKU community
People with PKU, caregivers and metabolic teams help shape what we build and how it fits into care.
We only use your details to contact you about Omaroon early access. We never sell your information, and you can ask to be removed at any time by emailing info@omaroon.com.
The PQS1.0 is in development. It is not available for sale and has not been cleared or approved by the FDA. Please don't include personal health information in this form.
Join the early access list
It takes less than a minute. Fields marked * are required.